Background Studies evaluating insurance status and melanoma outcomes are limited.
Objective We investigated whether health insurance correlates with more advanced …

Background Health insurance plays a critical role in the accessibility to and quality of health
care for patients with melanoma in the United States. Current knowledge regarding the …

BACKGROUND: Hispanics are given the diagnosis of melanoma at later stages and have
reduced survival. OBJECTIVE: We sought to evaluate the effect of Hispanic ethnicity and …

Background Despite encouraging trends in survival, sociodemographic inequalities persist
among patients with melanoma. Objective We sought to quantify the effect of race/ethnicity …

Background Despite improvements in melanoma mortality, disparities in melanoma survival
persist. We evaluated possible sociodemographic and health care–based predictors of …

Black patients were more likely to present at a late stage, which included stage III or IV at
diagnosis (P\. 001)(Table I). Further, patients with Medicaid were significantly more likely to …

Disparities in melanoma care exist in the United States. Disparities in provider type, patient
demographics, place of residence, insurance status, socioeconomic status, race/ethnicity …

Background: Ambulatory visits to dermatologists and primary care physicians (PCPs) may
improve melanoma outcomes through early detection. We sought to measure the effect of …

Background While the clinical implications of advanced melanoma have been extensively
documented, little is known about the direct medical costs associated with the disease …

Objective To assess health care resources consumed by melanoma in the population 65
years or older, a group with comparatively poor outcomes. Design Database analysis …